Caldolor launched ahead of schedule in U.S. by Cumberland Pharmaceuticals (News-Medical-Net)
Posted by Yahoo! News Search Results for natural alternative medicine on September 9, 2009
Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) announced today that it has successfully implemented the U.S. launch of Caldolor((R)), an intravenous formulation of ibuprofen, designed primarily for use in the hospital setting.
